Defining pseudoprogression in glioblastoma multiformeElke Van Mieghem, Paul M. Clément, Steven De Vleeschouwer et al.|European Journal of Neurology|2013Cited by 55
<i>MGMT</i> promoter methylation and <i>IDH1</i> mutation as prognostic markers for a favorable clinical outcome in patients with glioblastoma multiforme.Agnieszka Woźniak, Paul M. Clément, Elke Van Mieghem et al.|Journal of Clinical Oncology|2010Cited by 1